Literature DB >> 21113198

Slit2/Robo1 signaling in glioma migration and invasion.

Yun Xu1, Wen-Liang Li, Li Fu, Feng Gu, Yong-Jie Ma.   

Abstract

Slit2/Robo1 is a conserved ligand-receptor system, which greatly affects the distribution, migration, axon guidance and branching of neuron cells. Slit2 and its transmembrane receptor Robo1 have different distribution patterns in gliomas. The expression of Slit2 is at very low levels in pilocytic astrocytoma, fibrillary astrocytoma and glioblastoma, while Robo1 is highly expressed in different grades of gliomas at both mRNA and protein levels. Acquisition of insidious invasiveness by malignant glioma cells involves multiple genetic alterations in signaling pathways. Although the specific mechanisms of tumor-suppressive effect of Slit2/Robo1 have not been elucidated, it has been proved that Slit2/Robo1 signaling inhibits glioma cell migration and invasion by inactivation of Cdc42-GTP. With the research development on the molecular mechanisms of Slit2/Robo1 signaling in glioma invasion and migration, Slit2/Robo1 signaling may become a potential target for glioma prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21113198      PMCID: PMC5560338          DOI: 10.1007/s12264-010-0730-9

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  27 in total

1.  Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway.

Authors:  K Wong; X R Ren; Y Z Huang; Y Xie; G Liu; H Saito; H Tang; L Wen; S M Brady-Kalnay; L Mei; J Y Wu; W C Xiong; Y Rao
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

Review 2.  Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes.

Authors:  Kit Wong; Hwan Tae Park; Jane Y Wu; Yi Rao
Journal:  Curr Opin Genet Dev       Date:  2002-10       Impact factor: 5.578

3.  New neurons follow the flow of cerebrospinal fluid in the adult brain.

Authors:  Kazunobu Sawamoto; Hynek Wichterle; Oscar Gonzalez-Perez; Jeremy A Cholfin; Masayuki Yamada; Nathalie Spassky; Noel S Murcia; Jose Manuel Garcia-Verdugo; Oscar Marin; John L R Rubenstein; Marc Tessier-Lavigne; Hideyuki Okano; Arturo Alvarez-Buylla
Journal:  Science       Date:  2006-01-12       Impact factor: 47.728

4.  Neuronal chemorepellent Slit2 inhibits vascular smooth muscle cell migration by suppressing small GTPase Rac1 activation.

Authors:  Dong Liu; Jie Hou; Xing Hu; Xuerong Wang; Yan Xiao; Yongshan Mou; Hector De Leon
Journal:  Circ Res       Date:  2006-01-26       Impact factor: 17.367

Review 5.  The WHO classification of tumors of the nervous system.

Authors:  Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

6.  Frequent epigenetic inactivation of the SLIT2 gene in gliomas.

Authors:  Ashraf Dallol; Dietmar Krex; Luke Hesson; Charis Eng; Eamonn R Maher; Farida Latif
Journal:  Oncogene       Date:  2003-07-17       Impact factor: 9.867

7.  Activation of the repulsive receptor Roundabout inhibits N-cadherin-mediated cell adhesion.

Authors:  Jinseol Rhee; Najmus S Mahfooz; Carlos Arregui; Jack Lilien; Janne Balsamo; Mark F A VanBerkum
Journal:  Nat Cell Biol       Date:  2002-10       Impact factor: 28.824

8.  Robo4 is a vascular-specific receptor that inhibits endothelial migration.

Authors:  Kye Won Park; Clayton M Morrison; Lise K Sorensen; Christopher A Jones; Yi Rao; Chi-Bin Chien; Jane Y Wu; Lisa D Urness; Dean Y Li
Journal:  Dev Biol       Date:  2003-09-01       Impact factor: 3.582

9.  Slit2 involvement in glioma cell migration is mediated by Robo1 receptor.

Authors:  Sonja Mertsch; Nicole Schmitz; Astrid Jeibmann; Jian-Guo Geng; Werner Paulus; Volker Senner
Journal:  J Neurooncol       Date:  2007-10-30       Impact factor: 4.130

Review 10.  Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Authors:  Frank B Furnari; Tim Fenton; Robert M Bachoo; Akitake Mukasa; Jayne M Stommel; Alexander Stegh; William C Hahn; Keith L Ligon; David N Louis; Cameron Brennan; Lynda Chin; Ronald A DePinho; Webster K Cavenee
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

View more
  24 in total

1.  Slit2 regulates the dispersal of oligodendrocyte precursor cells via Fyn/RhoA signaling.

Authors:  Xiujie Liu; Yan Lu; Yong Zhang; Yuanyuan Li; Jiazhen Zhou; Yimin Yuan; Xiaofei Gao; Zhida Su; Cheng He
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

2.  Long Noncoding RNA MALAT-1 Can Predict Metastasis and a Poor Prognosis: a Meta-Analysis.

Authors:  Lucheng Zhu; Jihong Liu; Shenglin Ma; Shirong Zhang
Journal:  Pathol Oncol Res       Date:  2015-07-10       Impact factor: 3.201

Review 3.  Long non-coding RNAs in cancer invasion and metastasis.

Authors:  Xiao-han Shen; Peng Qi; Xiang Du
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

4.  Immunohistochemical staining of slit2 in primary and metastatic prostatic adenocarcinoma.

Authors:  Tanner L Bartholow; Michael J Becich; Uma R Chandran; Anil V Parwani
Journal:  Transl Oncol       Date:  2011-10-01       Impact factor: 4.243

5.  MicroRNA-219-5p exerts tumor suppressor function by targeting ROBO1 in glioblastoma.

Authors:  Yongmei Jiang; Lin Yin; Huirong Jing; Hui Zhang
Journal:  Tumour Biol       Date:  2015-06-17

6.  The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells.

Authors:  Tony Gutschner; Monika Hämmerle; Moritz Eissmann; Jeff Hsu; Youngsoo Kim; Gene Hung; Alexey Revenko; Gayatri Arun; Marion Stentrup; Matthias Gross; Martin Zörnig; A Robert MacLeod; David L Spector; Sven Diederichs
Journal:  Cancer Res       Date:  2012-12-14       Impact factor: 12.701

7.  SLIT2 inhibits cell migration in colorectal cancer through the AKT-GSK3β signaling pathway.

Authors:  Wei-Feng Chen; Wei-Dong Gao; Quan-Lin Li; Ping-Hong Zhou; Mei-Dong Xu; Li-Qing Yao
Journal:  Int J Colorectal Dis       Date:  2013-01-13       Impact factor: 2.571

8.  Frequent alterations of SLIT2-ROBO1-CDC42 signalling pathway in breast cancer: clinicopathological correlation.

Authors:  Rittwika Bhattacharya; Nupur Mukherjee; Hemantika Dasgupta; Md Saimul Islam; Neyaz Alam; Anup Roy; Priyobrata Das; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  J Genet       Date:  2016-09       Impact factor: 1.166

Review 9.  A roundabout way to cancer.

Authors:  Mimmi S Ballard; Lindsay Hinck
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

Review 10.  The potential of Slit2 as a therapeutic target for central nervous system disorders.

Authors:  Prativa Sherchan; Zachary D Travis; Jiping Tang; John H Zhang
Journal:  Expert Opin Ther Targets       Date:  2020-05-15       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.